- Home
- SA vs AVDL Comparison
SA vs AVDL Comparison
Compare SA & AVDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SA
- AVDL
- Stock Information
- Founded
- SA 1979
- AVDL 2015
- Country
- SA Canada
- AVDL Ireland
- Employees
- SA N/A
- AVDL N/A
- Industry
- SA Precious Metals
- AVDL Biotechnology: Pharmaceutical Preparations
- Sector
- SA Basic Materials
- AVDL Health Care
- Exchange
- SA Nasdaq
- AVDL Nasdaq
- Market Cap
- SA 1.0B
- AVDL 786.3M
- IPO Year
- SA N/A
- AVDL 1996
- Fundamental
- Price
- SA $12.58
- AVDL $8.02
- Analyst Decision
- SA
- AVDL Strong Buy
- Analyst Count
- SA 0
- AVDL 6
- Target Price
- SA N/A
- AVDL $20.00
- AVG Volume (30 Days)
- SA 577.1K
- AVDL 1.8M
- Earning Date
- SA 03-28-2025
- AVDL 03-03-2025
- Dividend Yield
- SA N/A
- AVDL N/A
- EPS Growth
- SA N/A
- AVDL N/A
- EPS
- SA N/A
- AVDL N/A
- Revenue
- SA N/A
- AVDL $138,160,000.00
- Revenue This Year
- SA N/A
- AVDL $515.63
- Revenue Next Year
- SA N/A
- AVDL $49.32
- P/E Ratio
- SA N/A
- AVDL N/A
- Revenue Growth
- SA N/A
- AVDL 1523.50
- 52 Week Low
- SA $9.31
- AVDL $7.39
- 52 Week High
- SA $20.55
- AVDL $19.09
- Technical
- Relative Strength Index (RSI)
- SA 53.83
- AVDL 35.71
- Support Level
- SA $11.57
- AVDL $7.40
- Resistance Level
- SA $12.78
- AVDL $8.07
- Average True Range (ATR)
- SA 0.43
- AVDL 0.35
- MACD
- SA 0.14
- AVDL 0.08
- Stochastic Oscillator
- SA 79.34
- AVDL 34.33
About SA Seabridge Gold Inc. (Canada)
Seabridge Gold Inc is a development stage company involved in the exploration, and development of gold properties sited in North America. The company's principal projects include the Kerr-Sulphurets-Mitchell property located in British Columbia, the Courageous Lake property located in the Northwest Territories, and Iksut Property located in northwestern British Columbia, and the 3 Aces Project in southeast Yukon. The company has various other mineral resource projects throughout North America.
About AVDL Avadel Pharmaceuticals plc
Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. It identifies, develops, and commercializes branded pharmaceutical products including controlled-release therapeutic products based on its proprietary drug delivery technologies in the United States. The company is engaged in development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy.